Tonix Pharmaceuticals Ownership | Who Owns Tonix Pharmaceuticals?


OverviewForecastRevenueFinancialsChart

Tonix Pharmaceuticals Ownership Summary


Tonix Pharmaceuticals is owned by 32.12% institutional investors, 0.03% insiders, and 67.85% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.30% of TNXP shares. iShares Russell 2000 ETF is the top mutual fund, with 2.10% of its assets in Tonix Pharmaceuticals shares.

TNXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTonix Pharmaceuticals32.12%0.03%67.85%
SectorHealthcare Stocks 42.52%10.81%46.67%
IndustryBiotech Stocks 45.18%10.75%44.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de681.53K9.30%$16.47M
Vanguard group556.96K7.60%$13.46M
Geode capital management200.93K2.74%$4.86M
Northern trust169.69K2.32%$4.10M
State street152.54K2.08%$3.69M
Capital fund management62.95K0.86%$1.52M
Ubs group51.58K0.70%$1.25M
Fmr45.47K0.62%$1.10M
Susquehanna portfolio strategies41.45K0.57%$1.00M
Squarepoint ops31.63K0.43%$764.25K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Abacus wealth partners15.00K0.05%$362.40K
Xtx topco20.30K0.03%$490.35K
Susquehanna portfolio strategies41.45K0.02%$1.00M
Gen-wealth partners533.000.00%$12.88K
Capital fund management62.95K0.00%$1.52M
Engineers gate manager lp8.71K0.00%$210.51K
Tower research capital llc (trc)3.46K0.00%$83.57K
Nisa investment advisors14.80K0.00%$357.57K
Cibc asset management17.57K0.00%$424.44K
Dogwood wealth management110.000.00%$2.66K

Top Buyers

HolderShares% AssetsChange
Vanguard group556.96K0.00%392.23K
Blackrock funding, inc. /de681.53K0.00%261.08K
Capital fund management62.95K0.00%62.95K
Fmr45.47K0.00%32.71K
Squarepoint ops31.63K0.00%31.63K

Top Sellers

HolderShares% AssetsChange
Nuveen15.37K0.00%-36.52K
Hrt financial lp---27.19K
Virtu financial---16.88K
Equitable---10.53K
Ifp advisors---10.00K

New Positions

HolderShares% AssetsChangeValue
Capital fund management62.95K0.00%62.95K$1.52M
Squarepoint ops31.63K0.00%31.63K$764.25K
Wellington management group llp26.46K0.00%26.46K$639.39K
Xtx topco20.30K0.03%20.30K$490.35K
Abacus wealth partners15.00K0.05%15.00K$362.40K

Sold Out

HolderChange
Raymond james financial-7.00
Fny investment advisers-1.10K
Jt stratford-6.44K
State board of administration of florida retirement system-6.92K
Ifp advisors-10.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20256042.86%2,353,52474.63%329.49%4330.30%716.67%
Jun 30, 20254684.00%1,387,046186.68%1828.41%37164.29%6-45.45%
Mar 31, 20251-96.97%10,000-99.93%-0.40%1-96.15%--100.00%
Dec 31, 20243383.33%14,675,7791331.33%623808.00%26100.00%4300.00%
Sep 30, 202418-14.29%1,025,324242.52%-3072.85%13-38.10%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF184.48K2.10%-
Northern Small Cap Value90.65K1.23%90.65K
NT Quality Small Cap Value90.65K1.23%90.65K
Vanguard Institutional Extnd Mkt Idx Tr79.62K1.06%-34.93K
Nuveen Quant Small Cap Equity R681.40K0.93%81.40K
Fidelity Small Cap Index76.03K0.87%76.03K
iShares Russell 2000 Value ETF65.65K0.75%-
Nuveen Equity Index R642.05K0.57%42.05K
State St Russell Sm/Mid Cp® Indx SL Cl I35.30K0.48%12.00K
Vanguard Russell 2000 ETF36.09K0.48%-2.46K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 21, 2025Taylor Carolyn E.-Buy$15.06K
Aug 20, 2025Treco James-Buy$9.00K
May 15, 2025LEDERMAN SETH Chief Executive OfficerBuy$86.20K
Jun 29, 2022LEDERMAN SETH Chief Executive OfficerBuy$34.20K
Mar 25, 2022LEDERMAN SETH Chief Executive OfficerBuy$24.50K

Insider Transactions Trends


DateBuySell
2025 Q32-
2025 Q21-
2025 Q1--
2024 Q2--
2024 Q1--

TNXP Ownership FAQ


Who Owns Tonix Pharmaceuticals?

Tonix Pharmaceuticals shareholders are primarily institutional investors at 32.12%, followed by 0.03% insiders and 67.85% retail investors. The average institutional ownership in Tonix Pharmaceuticals's industry, Biotech Stocks , is 45.18%, which Tonix Pharmaceuticals falls below.

Who owns the most shares of Tonix Pharmaceuticals?

Tonix Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (681.53K shares, 9.30%), Vanguard group (556.96K shares, 7.60%), and Geode capital management (200.93K shares, 2.74%). Together, they hold 19.64% of Tonix Pharmaceuticals’s total shares outstanding.

Does Blackrock own Tonix Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Tonix Pharmaceuticals.

Who is Tonix Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Abacus wealth partners is Tonix Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 15K Tonix Pharmaceuticals shares, valued at 362.4K$.

Who is the top mutual fund holder of Tonix Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Tonix Pharmaceuticals shares, with 2.10% of its total shares outstanding invested in 184.48K Tonix Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools